Twist Bioscience Corp (TWST): Operating Cash Flow
-$41.43M
Year ended 2026-09-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-09-30 | -$41.43M | n/m | 2026-11-16, From 2025-10-01 |
| 2025-09-30 | -$47.63M | n/m | 2026-11-16, From 2024-10-01 |
| 2024-09-30 | -$64.09M | n/m | 2026-11-16, From 2023-10-01 |
| 2023-09-30 | -$142.47M | n/m | 2025-11-17, From 2022-10-01 |
| 2022-09-30 | -$124.39M | n/m | 2024-11-18, From 2021-10-01 |
| 2021-09-30 | -$112.24M | n/m | 2023-11-21, From 2020-10-01 |
| 2020-09-30 | -$142.25M | n/m | 2023-06-05, From 2019-10-01 |
| 2019-09-30 | -$87.94M | n/m | 2021-11-23, From 2018-10-01 |
| 2018-09-30 | -$66.16M | n/m | 2020-11-27, From 2017-10-01 |
| 2017-09-30 | -$51.30M | n/a | 2019-12-13, From 2016-10-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | 2026-09-30 | -$41.43M | n/m |
| Tarsus Pharmaceuticals, Inc. (TARS) | 2025-12-31 | -$12.45M | n/m |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $50.40M | -57.5% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | -$10.71M | n/m |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $200.87M | +62.7% |
| Repligen Corp (RGEN) | 2025-12-31 | $117.42M | -33.1% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | -$45.99M | n/m |
| Vericel Corp (VCEL) | 2025-12-31 | $51.91M | -10.8% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | -$302.41M | n/m |
Compare TWST, TARS, ADMA, IMCR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗